newsfilter
← Latest News
Business Wire·

Appili Therapeutics Announces Results for Resolutions at Annual General Meeting of Shareholders

Capital Markets Veteran Josef Vejvoda to Join Appili Board of Directors as New Director Appili Therapeutics Inc. (TSX:APLI, OTCQX:APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases, tod